Search | IOVS | ARVO Journals

View

Showing 1 – 14 of 14

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2015

Sustained Release Biodegradable Steroid Formulations for Intravitreal Delivery

Sanjib Das; Stuart Williams; Janet Tully; Ayush Verma; Jeremy Hansen; Melissa Hernandez; Tyler Pegoraro; Tomas Navratil; Benjamin Maynor; Benjamin Yerxa

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4165. doi:

ARVO Annual Meeting Abstract June 2015

Fabrication of Shape and Size Specific Nanoparticles for Ocular Drug Delivery

Stuart Williams; Sanjib Das; Jeremy Hansen; Janet Tully; Melissa Hernandez; Tyler Pegoraro; Rozemarijn S Verhoeven; Benjamin Maynor; Benjamin Yerxa

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5026. doi:

ARVO Annual Meeting Abstract June 2015

In-Vitro Release of Bevacizumab from Hydrogel-based Drug Delivery Systems

Janet Tully; Stuart Williams; Kevin Herlihy; Gary Owens; Gabe Fawcett; Nicole Meyer; Tomas Navratil; Benjamin Maynor; Benjamin Yerxa

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):222. doi:

ARVO Annual Meeting Abstract June 2015

ESTABLISHING IN VIVO TO IN VITRO CORRELATIONS FOR THE RATE OF RELEASE OF BEVACIZUMAB FROM EXTENDED RELEASE FORMULATIONS

Gary Owens; Stuart Williams; Kevin Herlihy; Janet Tully; Rozemarijn S Verhoeven; Tomas Navratil; Benjamin Maynor; Benjamin Yerxa

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):236. doi:

ARVO Annual Meeting Abstract April 2014

Bioerodable Hydrophobic Intravitreal Implants for the Extended Release of Bevacizumab for Age Related Macular Degeneration

John Savage; Kevin Patrick Herlihy; Gary Owens; Jeremy Hansen; RiLee Robeson; Benjamin Maynor; Tomas Navratil; Brian C Gilger; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1951. doi:

ARVO Annual Meeting Abstract April 2014

Extended Release of Microfabricated Protein Particles from Biodegradable Hydrogel Implants for the Treatment of Age Related Macular Degeneration

Kevin Patrick Herlihy; Stuart Williams; Gary Owens; John Savage; Lindsay Gardner; RiLee Robeson; Benjamin Maynor; Tomas Navratil; Brian C Gilger; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1960. doi:

ARVO Annual Meeting Abstract April 2014

Preclinical Evaluation of ENV515 (travoprost) Intracameral Implant - Clinical Candidate for Treatment of Glaucoma Targeting Six-Month Duration of Action

Tomas Navratil; Andres Garcia; Janet Tully; Benjamin Maynor; Iqbal Ike K Ahmed; Donald L Budenz; Richard A Lewis; Steven L Mansberger; Brian C Gilger; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3548. doi:

ARVO Annual Meeting Abstract April 2014

Photocurable Hydrogel Implants for the Extended Release of Bevacizumab for the Treatment of Age Related Macular Degeneration

Stuart Williams; Kevin Herlihy; Gary Owens; John Savage; Lindsay Gardner; Janet Tully; Benjamin Maynor; Tomas Navratil; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):471. doi:

ARVO Annual Meeting Abstract April 2014

Controlled and Extended Release of Difluprednate from Biodegradable Intraocular Implants Engineered using PRINT® Technology

Ayush Verma; Jeff Kindig; Kyle Sebastian; Janet Tully; Andres Garcia; RiLee Robeson; Benjamin Maynor; Tomas Navratil; Brian C Gilger; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):476. doi:

ARVO Annual Meeting Abstract April 2014

Precisely Engineered Biodegradable Drug Delivery Systems for the Extended Release of Prostaglandin Analogues in the Anterior Chamber

Andres Garcia; Janet Tully; Sanjib Das; Tyler Pegoraro; Leo Trevino; Benjamin Maynor; Tomas Navratil; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5268. doi:

ARVO Annual Meeting Abstract April 2014

Development of Precisely-Engineered Biodegradable Drug Delivery Systems for Posterior Ocular Drug Delivery: PRINT® PLGA Extended Release Implants for anti-VEGF Biologics

Benjamin Maynor; Andres Garcia; Janet Tully; Gary Owens; RiLee Robeson; Tomas Navratil; Brian C Gilger; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5269. doi:

ARVO Annual Meeting Abstract April 2014

Intracameral Conversion of Travoprost to Travoprost Acid in the Normotensive Beagle Dog Model

Leo Trevino; Tomas Navratil; RiLee Robeson; Andres Garcia; Janet Tully; Michael Hunter; Daria Stoltz; Benjamin Maynor; Brian C Gilger; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5270. doi:

ARVO Annual Meeting Abstract June 2013

Precisely Engineered Biodegradable Intraocular Implants for the Sustained Release of Dexamethasone

Andres Garcia; Janet Tully; Benjamin Maynor; Benjamin Yerxa

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1079. doi:

ARVO Annual Meeting Abstract June 2013

Application of PRINT Microparticle and Nanoparticle Technology Toward Preparation of Ophthalmic Suspension Formulations with Improved Tolerability and Efficacy

Benjamin Maynor; Andres Garcia; Janet Tully; Benjamin Yerxa

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1091. doi:

Advertisement